Drug Shortage Report for BYETTA

Last updated on 2017-09-07
Report ID 18193
Drug Identification Number 02361817
Brand name BYETTA
Common or Proper name exenatide injection
Company Name ASTRAZENECA CANADA INC
Active Ingredient(s) EXENATIDE
Strength(s) 250MCG
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS
Packaging size 2.4 mL prefilled pen
ATC code A10BJ
ATC description BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
Reason for shortage Demand increase for the drug.
Anticipated start date 2017-08-14
Actual start date
Estimated end date 2017-09-04
Actual end date 2017-09-06
Shortage status Resolved
Updated date 2017-09-06
Company comments
Health Canada comments
Company contact information Please contact AstraZeneca Canada Medical Information for any specific questions at 1-800-668-6000 (EN) or 1-800-461-3787 (FR) or by email: medinfo.canada@astrazeneca.com.